News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
43
Sources here
19
Companies here
10
Search results Stored financial headlines

Active search

43 matching headlines

Ticker or company: GXIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Gerresheimer seals $1.7bn deal to sell two packaging businesses to Apax

Gerresheimer has agreed to offload Centor and its global Primary Packaging Plastics business to an affiliate of funds advised by private equity company Apax Partners. The two units have a combined enterprise value of €1.5bn ($1.7bn). No other financial terms were made public. Each …

GXI main company
Sharemaestro market context Trend signal active 52 weeks -41.0% · Next-week setup negative 41.7% GXI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jiangxi Biological (6915.HK) has officially commenced production at its veterinary TAT manufacturing line, with commercialization providing further catalyst for stock price recovery.

6915 main company
Sharemaestro market context Stored weekly price path 7 weeks +119.8% · Next-week setup positive 61.3% 6915 stored weekly price path from 3 Jul 2026 to 14 Aug 2026

Gerresheimer Starts Operations at New Plant in Zhenjiang Dagang, China

DUESSELDORF, GERMANY and ZHENJIANG DAGANG, CHINA - July 23, 2026 (NEWMEDIAWIRE) - Gerresheimer, an innovative system and solution provider and global partner to the pharma, biotech, and cosmetic industries, has started operations at a new plant in Zhenjiang Dagang, China, for the production of …

GXI main company
Sharemaestro market context Trend signal active 52 weeks -41.0% · Next-week setup negative 41.7% GXI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context